CLINICAL RESEARCH

More in CLINICAL RESEARCH

• Experts call for India's proactive role in clinical research

  ​Pioneering in this regard, ETPharma curated a trialogue titled ‘Strategic Harmonisation in Multinational Trials: Navigating Challenges and Seizing Opportunities’ at the inaugural edition of the Clinical Research Excellence Conference 2024. The discussion focused on the opportunities India can capitalise on in the clinical research landscape. Discussing the ethical aspect, experts voiced continuous ‘upgradation programmes’ and focused on the ‘capability building’ of ethics committee members to make them aware of current trends and practices.

  • Exclusive

  

• Advancing clinical research: ETPharma’s CREC 2024 spotlights innovations and collaborations

  ​Discussions revolved around challenges, upholding ethical standards as unavoidable, and calls for openness, respect for participant choice, and strict privacy protections. The participants echoed that to succeed in this environment, researchers must possess an innovative and forward-thinking perspective, which will help them get over obstacles and produce good results that will eventually improve patient care and medical knowledge.

  • Exclusive

  

• Smart wearables going to revolutionise the clinical research scenario, says expert

  Dr Nilima Kshirsagar, National Chair, Clinical Pharmacology, ICMR, delved into this critical matter at the ETPharma Clinical Research Excellence Conference (CREC). She stated that fitness bands and chip based health measuring devices are going to revolutionise the clinical research sector and called for mandating Data and AI enabled cells in all medical academic institutions.

  • Exclusive

  

• ETPharma to host inaugural edition of Clinical Research Excellence Conference

  The inaugural edition of the ETPharma Clinical Research Excellence Conference themed ‘From Insights to Impact’ strives to discover the intersection of cutting-edge innovation, regulatory foresight, and operational excellence at the forefront of clinical research.

  • Exclusive

  

• The potential of India's nutraceutical market to thrive

  Interacting with ETHealthworld, several industry leaders in the Indian nutraceutical sector, share perspectives on the potential of the sector, and how the nutraceutical industry is revolutionising healthcare delivery not only in India but globally as the illness to wellness gains more traction as a global phenomenon.

  • Exclusive

  

• Gurugram University to provide advanced certificate course in Clinical Research

  ​One of the key highlights of this collaboration is the opportunity for students to receive guidance from highly qualified medical specialists throughout the course. The partnership will facilitate the organization of collaborative conferences, workshops, and seminars to enhance students' knowledge and expertise in clinical research. This hands-on approach to learning will provide students with a comprehensive understanding of the field and equip them with the necessary skills to excel in their future careers.

  

• China's Stemirna halts mRNA cancer vaccine trial, researchers say

  The charity Cancer Council South Australia, which provides information on clinical cancer trials, said on its website that Stermirna's study was still recruiting participants. The council told Reuters in a statement that it did not fund any trials it listed on its website and referred questions to trial investigators.

  

• ICRI announces partnership with Mumbai's PD Hinduja Hospital

  The PG course is designed to provide training, experience, and innovation at world-class hospitals with international standards of technology and infrastructure.

  

• Ex-Blackstone India co-head Mathew Cyriac’s fund buys 80% stake in Accutest Research Laboratories

  In the next five years, drug patents with sales worth $170 billion will expire globally, driving demand for cost-effective generic drugs. Among the drugs losing patent, the share for specialty medicines like Biologics, inhalers, injectables, and transdermal is 54%, and the remaining 46% is oral. As a result, Accutest services are increasingly focused on specialty medicines.

  

• Parexel promotes Peyton Howell, Amy McKee to strengthen company’s medical, scientific focus

  Peyton Howell has been promoted to the newly-created role of Chief Operating and Growth Officer and Dr Amy McKee has been appointed as the Chief Medical Officer and Global Head, Oncology Centre of Excellence. As Chief Operating and Growth Officer, Howell will lead Parexel’s operational delivery, strategy and growth.

  

• India’s clinical research advancements: trends witnessed across technology and patient-centricity

  Brand Connect Initiative